Ginkgo Bioworks Holdings Inc. Class A (DNA) Share Price Today, Stock Analysis, Annual Report | Value Research Ginkgo Bioworks Holdings Inc. Class A (DNA) - Get live share price today, stock analysis, price valuation, performance, fundamentals, market cap, share holding, financial report of US stocks.

Ginkgo Bioworks Holdings Inc. Class A (DNA)

Download Stock Report

NYSE: DNA

  • Price Change
  • Market Capitalisation market-capitalisation-info $2,669 Mln

  • 12 Month Earnings monthly-earning $-1,719 Mln
  • Price to Earnings price-to-earning --

Ginkgo Bioworks Holdings Inc. Class A (DNA) Share Price

$1.77

As on 22-Sep-2023 16:10 EDT

up-down-arrow $0.021.14%

  • Prev Close info

    $1.75

  • Day's Openinfo

    $1.77

  • Today's Highinfo

    $1.81

  • Today's Lowinfo

    $1.74

  • Today's Volumeinfo

    14,829,668

Please wait...

Ginkgo Bioworks Holdings Inc. Class A (DNA) Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Ginkgo Bioworks Holdings Inc. Class A (DNA)
4.73 6.63 0.00 -38.33 -- -- --
S&P BSE Sensex
8.49 1.22 3.91 11.02 20.17 12.37 12.54
S&P Small-Cap 600#
-0.96 -4.96 -1.70 6.06 11.70 1.31 6.60
As on 22-Sep-2023  |  #As on 24-Sep-2023
2022
Ginkgo Bioworks Holdings Inc. Class A (DNA)
-79.66
S&P Small-Cap 600
-17.42
S&P BSE Sensex
4.44

Valuation

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Ginkgo Bioworks Holdings Inc. Class A (DNA) Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of Ginkgo Bioworks Holdings Inc. Class A (DNA)

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Founder, CEO & Director

        Dr. Jason Kelly

        Founder, Pres, COO & Director

        Dr. Reshma P. Shetty

        Headquarters

        Boston, MA

        FAQs for Ginkgo Bioworks Holdings Inc. Class A (DNA)

        The total asset value of Ginkgo Bioworks Holdings Inc. Class A (DNA) stood at $ 2,609 Mln as on 31-Mar-23

        The share price of Ginkgo Bioworks Holdings Inc. Class A (DNA) is $1.770000 (NYSE) as of 22-Sep-2023 16:10 EDT. Ginkgo Bioworks Holdings Inc. Class A (DNA) has given a return of -38.33% in the last 1 years.

        Ginkgo Bioworks Holdings Inc. Class A (DNA) has a market capitalisation of $ 2,669 Mln as on 19-May-2023. As per Value Research classification, it is a Small Cap company.

        The P/B ratio of Ginkgo Bioworks Holdings Inc. Class A (DNA) is 2.46 times as on 19-May-2023, a -0.03% premium to its peers’ median range of 2.54 times.

        Since, TTM earnings of Ginkgo Bioworks Holdings Inc. Class A (DNA) is negative, P/E ratio is not available.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Ginkgo Bioworks Holdings Inc. Class A (DNA) and enter the required number of quantities and click on buy to purchase the shares of Ginkgo Bioworks Holdings Inc. Class A (DNA).

        Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

        The CEO & director of Dr. Jason Kelly. is Ginkgo Bioworks Holdings Inc. Class A (DNA), and CFO & Sr. VP is Dr. Reshma P. Shetty.

        The promoters of Ginkgo Bioworks Holdings Inc. Class A (DNA) have pledged 0% of the total equity as on Mar-23.

        Ginkgo Bioworks Holdings Inc. Class A (DNA) Ratios
        Return on equity(%)
        -112.99
        Return on capital employed(%)
        --
        Debt-to-equity ratio
        0
        Dividend yield(%)
        0

        No, TTM profit after tax of Ginkgo Bioworks Holdings Inc. Class A (DNA) was $-1,719 Mln.

        Edit peer-selector-edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information $2,669.44 Mln
        • Revenue (TTM)revenue-information $390.00 Mln
        • Earnings (TTM) earning-information $-1,719.39 Mln
        • Cash date-information $1,206.09 Mln
        • Total Debt info $404.10 Mln
        • Insider's Holding 9.21%
        • Liquidity liquidity High
        • 52 Week range week-range $1.12 - 3.52
        • Shares outstanding share-outstanding 1,585,289,984

        About The Company

        • IPO Date 19-Apr-2021
        • Founder, CEO & Director Dr. Jason Kelly
        • Founder, Pres, COO & Director Dr. Reshma P. Shetty
        • Listing key-listing NYSE: DNA
        • Country United States
        • Headquarters headquarters Boston, MA
        • Website website https://www.ginkgobioworks.com
        • Business

          Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals...  derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.  Read more

        Demystifying Stocks.

        At Value Research, we believe it's best to understand investments before diving in. And since 1990, we've been doing exactly that – helping & guiding lakhs of Indians with their investing journey. Join the journey.

        Sign Up for Free
        demystifying-mutual-fund

        What can Value Research do for you?

        solidify-your-fundamentals
        Solidify your fundamentals

        Learn the principles, mindset and tools you need to become a successful Mutual Fund and Stock investor from the masters who have been doing this for decades.

        track-all-your-investments
        Track all your investments

        Use India's most advanced investment tracker to track, analyse and get updates and insights on your investments.

        get-guidance-from-our-experts
        Get guidance from our experts

        Get an analysis of your portfolio along with actionable, general tips and insights, guidance on where to invest based on your goals, and experts' opinions on individual Mutual Funds and Stocks.

        get-access-to-exclusive-analytics
        Get access to exclusive analytics

        Value Research offers the most advanced and detailed data & analytics available on Mutual Funds and Stocks. Sign up and unlock the power yourself.

        Explore it yourself, for free

        Sign up and get access to:

        Unlimited access to advice from India's top experts

        The most comprehensive analysis of funds and stocks in India

        A holistic portfolio manager to help track all your investments easily

        And much more, like guides, tools, webinars, videos and eBooks.

        share-fund-plan-icon